Modular Medical Locks In All Three Top PBMs for Pivot Pump, Covering 182M+ Lives
MODD sits 31% above its 52-week low of $1.195.
Summary
Modular Medical signed agreements with the last two of the three largest U.S. pharmacy benefit managers for its Pivot tubeless patch pump, completing coverage across all three. Those PBM networks together reach more than 182 million lives and process roughly 80% of U.S. prescription claims, though actual patient coverage still depends on each health plan's formulary and benefit design. This builds on the single national PBM contract disclosed in early September and the FDA clearance of Pivot software enhancements the day before. For a company with a market value under $20 million, a $7.1 million quarterly loss and $5.1 million of cash at September 30, broad reimbursement access is the gating item for converting a cleared device into revenue. The contracts are a foundation, not a revenue number — no volumes, pricing or launch dates were disclosed. Watch the commercial launch rollout the CEO referenced for the coming year, and the company's ability to fund it given the going-concern language in the November 16 10-Q.
At the time of this announcement, MODD was trading at $1.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.7M. The 52-week trading range was $1.20 to $16.20. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.